These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1227657)

  • 1. [Modifying effect of darkness on the growth of mammary cancer and on the efficacy of experimental hormone therapy].
    Kuralasov AK
    Biull Eksp Biol Med; 1975 Jul; 80(7):82-4. PubMed ID: 1227657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Causes of renewed growth of mammary gland cancer metastases during hormone therapy].
    Lazarev NI; Kuralasov AK; Chalov MKh
    Biull Eksp Biol Med; 1967 Nov; 63(11):118-21. PubMed ID: 5633414
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of a transplantable mammary gland cancer in rats at different thyroid hormone levels].
    Dedov II; Demina NA
    Vopr Onkol; 1979; 25(5):47-50. PubMed ID: 462853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental findings in support of hormone therapy for breast cancer].
    Kuralasov AK; Mezinova NN; Lazarev NI
    Vopr Onkol; 1976; 22(9):43-6. PubMed ID: 827118
    [No Abstract]   [Full Text] [Related]  

  • 5. [The anti-tumor effectiveness of hormones in rat mammary gland neoplasms].
    Beskrovnyĭ AM
    Vopr Onkol; 1971; 17(9):95-8. PubMed ID: 5138815
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypophysectomy and injections of high doses of estrogens inhibit the growth of ovary-independent rat mammary carcinomas.
    Nomura S; Yoshida H; Kaneko Y
    In Vivo; 1990; 4(2):121-5. PubMed ID: 1966585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a slow-growing, transplantable rat mammary tumor (MCR-83): a model for endocrine-related cell kinetic studies.
    van Dierendonck JH; Cornelisse CJ; van der Linden PW; van Putten LM; van de Velde CJ
    Cancer Res; 1987 Aug; 47(15):4093-8. PubMed ID: 3607751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dichotomous effects of tamoxifen on a transplantable rat mammary tumor.
    Ip MM; Milholland RJ; Rosen F; Kim U
    Cancer Res; 1981 Mar; 41(3):984-8. PubMed ID: 7459886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
    Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
    Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of heterogeneous anti-organ sera on metastasis of transplantable mammary carcinoma in rats (RMC-1)].
    Khundanova LL
    Biull Eksp Biol Med; 1966 Oct; 62(10):86-9. PubMed ID: 6005608
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of high-dose progesterone on growth of rat mammary carcinoma.
    Diamond EJ; Koprak S; Hollander VP
    Cancer Res; 1980 Apr; 40(4):1091-6. PubMed ID: 7357540
    [No Abstract]   [Full Text] [Related]  

  • 12. [Growth of transplantable aflatoxin B1-induced mammary cancer in Wistar rats during treatment with BCG vaccine].
    Leszczyszyn J
    Patol Pol; 1986; 37(3):222-36. PubMed ID: 3104870
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of the light regime and electromagnetic fields on mammary carcinogenesis in female rats].
    Anisimov VN; Zhukova OV; Veniashvili DSh; Bilanishvili VG; Menabde MZ; Gupta D
    Biofizika; 1996; 41(4):807-14. PubMed ID: 8962882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-inhibiting potential of ZK 112.993, a new progesterone antagonist, in hormone-sensitive, experimental rodent and human mammary tumors.
    Schneider MR; Michna H; Nishino Y; Neef G; el Etreby MF
    Anticancer Res; 1990; 10(3):683-7. PubMed ID: 2369083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor efficacy in rats of CGP 19984, a thiazolidinedione derivative that inhibits luteinizing hormone secretion.
    Ip MM; Sylvester PW; Schenkel L
    Cancer Res; 1986 Apr; 46(4 Pt 1):1735-40. PubMed ID: 3948162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effect of electrochemical therapy on transplantable mouse cancers.
    Wójcicki M; Droździk M; Olewniczak S; Opolski A; Wietrzyk J; Radzikowski C; Kaczmarek B; Wrzesiński M; Romanowski M; Kamiński M; Zieliński S
    Med Sci Monit; 2000; 6(3):498-502. PubMed ID: 11208360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pharmacological doses of estrogen on ovary-independent rat mammary carcinoma containing estrogen and progesterone receptors.
    Yoshida H; Fukuhara T; Yamashi S; Yoshida A; Fukunishi R; Tsuji M; Matsumoto K
    Cancer Res; 1983 May; 43(5):2311-6. PubMed ID: 6403234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein alone or combined with cyclophosphamide may stimulate 16/C transplantable mouse mammary cancer growth.
    Wietrzyk J; Mazurkiewicz M; Madej J; Dzimira S; Grynkiewicz G; Radzikowski C; Opolski A
    Med Sci Monit; 2004 Nov; 10(11):BR414-9. PubMed ID: 15507846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental gene therapy in mammary and urinary bladder cancer using electrogene transfer.
    Shibata MA; Morimoto J; Ito Y; Kusakabe K; Otsuki Y
    Med Electron Microsc; 2004 Dec; 37(4):216-24. PubMed ID: 15614446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of an epidermal growth factor-like growth factor by epidermal growth factor-independent rat mammary carcinoma cells.
    Ethier SP; Moorthy R; Dilts CA
    Cell Growth Differ; 1991 Nov; 2(11):593-602. PubMed ID: 1726054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.